advances in novel adcs for her2-expressing breast cancer
Published 2 years ago • 226 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
2:21
adcs for the treatment of her2-low breast cancer
-
3:01
resistance to adcs in breast cancer and novel combination strategies
-
6:51
adcs for her2 and her2-low breast cancer
-
2:00
advances in antibody-drug conjugates for breast cancer at esmo 2022
-
0:46
what does the future hold for adcs in breast cancer?
-
4:45
advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
-
1:02
combination therapies incorporating adcs in breast cancer
-
1:10
do adcs have a future in treating breast cancer?
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc
-
2:03
gmf-1a3, a novel adc targeting cleaved amphiregulin in breast cancer
-
0:49
breast cancer at esmo 2023: adcs and monarch 3
-
1:49
the latest clinical research on adcs in breast cancer
-
50:55
advancements and applications of antibody drug conjugates in her2-negative breast cancer
-
1:58
novel therapies for her2 metastatic breast cancer
-
1:23
antibody-drug conjugates for the treatment of breast cancer
-
1:09
where are we in sequencing adcs in hr breast cancer?
-
1:24
highlights from sabcs 2023: novel agents and insights on her2 dynamics in breast cancer
-
0:46
antibody-drug conjugates in gynecological cancers
-
0:54
moving adcs to first-line therapy in metastatic her2 breast cancer